Todd Herrington, MD, PhD

Director, Deep Brain Stimulation Program



About Dr. Herrington

Todd Herrington, MD, PhD

Todd Herrington, MD, PhD, is a neurologist at Massachusetts General Hospital and an assistant professor of Neurology at Harvard Medical School. Dr. Herrington completed his BS at Stanford University, followed by MD and PhD at Harvard Medical School, residency in Neurology at the joint Partners Neurology Residency Program at Massachusetts General Hospital and Brigham and Women’s Hospital, and a fellowship in Movement Disorders at Massachusetts General Hospital.

In the Division of Movement Disorders at MGH, Dr. Herrington treats patients with Parkinson’s disease, tremor, dystonia, and other movement disorders, with an additional specialization in patients who are undergoing treatment with deep brain stimulation.

Dr. Herrington’s research focuses on the impact of deep brain stimulation and cell therapies on the motor, cognitive, and psychiatric manifestations of movement disorders. Using a combination of intraoperative neurophysiology, noninvasive neurophysiology, and neuroimaging, Dr. Herrington aims to further our understanding of the role of the human basal ganglia in health and disease and to develop novel approaches to neuromodulation to treat motor and nonmotor symptoms.

Stay Updated!

The search for effective treatments for Parkinson’s disease is ongoing. Join our mailing list to stay up to date on the latest advances.

Related Content

Personalizing Stem Cell Therapy for Parkinson’s Disease

In the U.S. alone, as many as one million people have Parkinson’s disease. Kwang-Soo Kim, PhD, is committed to finding a way to lower those numbers.

First-in-Human Therapy With Stem Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease

MGH-McLean team have become the first to implant patient-derived midbrain dopaminergic progenitor cells into a patient with Parkinson’s.

Patient-Derived Dopamine Neurons Show Promise in Parkinson’s Treatment

A study published in the New England Journal of Medicine describes the innovative treatment of a Parkinson’s disease patient.